The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...

The complete response letter did not identify any issues with the safety or efficacy of Eylea HD, Regeneron officials said.

The FDA issued a complete response letter for a supplemental biologics license application, in which it did not approve ...

Regeneron Pharmaceuticals has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its Eylea HD eye drug.

BRIDGEWATER, N.J. and BENGALURU, Karnataka, India, April 15, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today a settlement and license agreement with ...

Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution for injection ... 8 mg supporting the blockbuster status of ...

Tanzi would be the third Death Row inmate to be executed in Florida this year. A 48-year-old man is to be executed by lethal injection in the southern US state of Florida on Tuesday for the April ...

How quickly can you solve it? Play now! Phillip Faraone/Getty “Here’s what I did: I got PRP (platelet-rich plasma) injections in my head, which caused my hair to grow in fuller and I grew out ...

NORSE EIGHT was a randomized, non-inferiority study of 400 newly diagnosed, wet AMD patients who received either 1.25 mg ONS-5010 or 0.5 mg Lucentis (ranibizumab) intravitreal injections. The primary ...

Macular edema is swelling in the eye's retina that causes blurry vision but can progress to more serious vision loss. The most common condition associated with macular edema is diabetic retinopathy, ...